Iran medicine damage has severely disrupted healthcare across the country following recent regional attacks. Authorities report that pharmaceutical production and distribution face major setbacks. Dr. Mahdi Pirsalehi, deputy health minister and head of Iran’s Food and Drug Administration, said attacks directly hit 24 pharmaceutical production units. He emphasized that the country continues to produce medicine despite these challenges.
Pirsalehi explained that attackers aimed to target medical and healthcare centers to interrupt emergency and routine operations. He stressed that such actions clearly violate international norms protecting healthcare during conflicts. Mohammad Hashemi, spokesperson for Iran’s Food and Drug Administration, said eight major drug manufacturing plants suffered damage. He added that several pharmaceutical companies also faced operational losses. Authorities are working to restore production quickly.
The attacks began on Saturday, February 28, with coordinated strikes by foreign forces. During this period, multiple areas in Iran, including the Kurdistan region, experienced repeated targeting. Iranian armed forces, particularly the Revolutionary Guards, launched counterattacks using drones and missiles against foreign military bases. These operations directly affected ongoing conflict dynamics and regional security.
According to the Ministry of Health and Red Crescent reports, 1,937 people died during these attacks. Moreover, more than 25,000 individuals sustained injuries. The health minister highlighted that attackers focused on healthcare and educational centers. He reported that 32 health centers and pharmacies faced destruction. In addition, 65 schools and educational institutions suffered partial or full damage. Authorities also recorded 28 damaged emergency and rescue vehicles.
Experts warn that Iran medicine damage could worsen if production and distribution interruptions continue. They recommend securing pharmaceutical supply chains to maintain public health services. Authorities stress that maintaining medicine production is critical for treating injuries and preventing public health crises. They prioritize restoring affected facilities as soon as possible.
Officials plan to enhance security at production and distribution centers. They aim to guarantee uninterrupted access to medicine for citizens. Iran medicine damage has raised international concern over protecting health services during conflicts. Authorities urge that safeguarding medical infrastructure remains essential for public welfare.